SAJAZIR Trademark

Trademark Overview


On Tuesday, January 12, 2021, a trademark application was filed for SAJAZIR with the United States Patent and Trademark Office. The USPTO has given the SAJAZIR trademark a serial number of 90461564. The federal status of this trademark filing is REGISTERED as of Tuesday, June 13, 2023. This trademark is owned by Cycle Pharmaceuticals Ltd.. The SAJAZIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceutical preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceuticals for the treatment of hereditary angioedema all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Veterinary preparations for treatment of intestinal bacteria; veterinar...
sajazir

General Information


Serial Number90461564
Word MarkSAJAZIR
Filing DateTuesday, January 12, 2021
Status700 - REGISTERED
Status DateTuesday, June 13, 2023
Registration Number7081259
Registration DateTuesday, June 13, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements


Goods and ServicesPharmaceutical agents for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceutical preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; pharmaceuticals for the treatment of hereditary angioedema all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations, namely, pain relief medications; veterinary preparations for medical treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals; supplements for the treatment of hereditary angioedema; supplements for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels and transdermal patches; chemical preparations for the medical treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels and transdermal patches; Drug delivery agents consisting of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents for use in pharmaceutical preparations, drugs and medicines for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; medical drugs for the treatment of rare diseases, in particular for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of hereditary angioedema, medical enzyme preparations in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; enzyme preparations for veterinary purposes; medicinal preparations for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; medicines for the treatment of hereditary angioedema, all in the form of liquids, topical solutions, liquid suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersible tablets, inhaled vapors, gases, and mists, topical creams and gels, and transdermal patches; Medical and veterinary preparations and articles, namely, pre-filled syringes containing a bradykinin B2 receptor antagonist for medical purposes; Pharmaceuticals and natural remedy preparations, for use in the treatment and management of hereditary angioedema; single-use pre-filled syringes containing a bradykinin B2 receptor antagonist; syringes sold filled with a bradykinin B2 receptor antagonist for subcutaneous injections in the treatment of acute attack of hereditary angioedema; single-use pre-filled syringes containing a bradykinin B2 receptor antagonist for subcutaneous injections in the treatment of acute attack of hereditary angioedema
Translation of Words in MarkThe wording SAJAZIR has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 12, 2021
Primary Code005
First Use Anywhere DateFriday, September 23, 2022
First Use In Commerce DateFriday, September 23, 2022

Trademark Owner History


Party NameCycle Pharmaceuticals Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCambridge CB30FA
GB

Party NameCycle Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCambridge CB30FA
GB

Party NameCycle Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCambridge CB30FA
GB

Trademark Events


Event DateEvent Description
Tuesday, June 13, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 13, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 4, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 18, 2023USE AMENDMENT FILED
Thursday, May 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 14, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 1, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, February 1, 2022FINAL REFUSAL E-MAILED
Tuesday, February 1, 2022FINAL REFUSAL WRITTEN
Thursday, January 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 28, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 28, 2021NON-FINAL ACTION WRITTEN
Wednesday, July 21, 2021ASSIGNED TO EXAMINER
Monday, April 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 15, 2021NEW APPLICATION ENTERED